IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v24y1995i4p609-630.html
   My bibliography  Save this article

External partnering as a response to innovation barriers and global competition in biotechnology

Author

Listed:
  • Greis, Noel P.
  • Dibner, Mark D.
  • Bean, Alden S.

Abstract

No abstract is available for this item.

Suggested Citation

  • Greis, Noel P. & Dibner, Mark D. & Bean, Alden S., 1995. "External partnering as a response to innovation barriers and global competition in biotechnology," Research Policy, Elsevier, vol. 24(4), pages 609-630, July.
    • Handle: RePEc:eee:respol:v:24:y:1995:i:4:p:609-630
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0048-7333(94)00789-6
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. David J. TEECE, 2008. "Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy," World Scientific Book Chapters, in: The Transfer And Licensing Of Know-How And Intellectual Property Understanding the Multinational Enterprise in the Modern World, chapter 5, pages 67-87, World Scientific Publishing Co. Pte. Ltd..
    2. Pisano, Gary P., 1991. "The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry," Research Policy, Elsevier, vol. 20(3), pages 237-249, June.
    3. Arora, Ashish & Gambardella, Alfonso, 1990. "Complementarity and External Linkages: The Strategies of the Large Firms in Biotechnology," Journal of Industrial Economics, Wiley Blackwell, vol. 38(4), pages 361-379, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Christian Lechner & Michael Dowling, 1999. "The Evolution of Industrial Districts and Regional Networks: The Case of the Biotechnology Region Munich/Martinsried," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 3(4), pages 309-338, December.
    2. Sarpong, David & AbdRazak, Azley & Alexander, Elizabeth & Meissner, Dirk, 2017. "Organizing practices of university, industry and government that facilitate (or impede) the transition to a hybrid triple helix model of innovation," Technological Forecasting and Social Change, Elsevier, vol. 123(C), pages 142-152.
    3. Sharmistha Bagchi-Sen & Helen Lawton Smith, 2014. "Firm Heterogeneity in Biotech: Absorptive Capacity, Strategies and Local-Regional Connections," European Planning Studies, Taylor & Francis Journals, vol. 22(9), pages 1783-1801, September.
    4. Sharmistha Bagchi-Sen & Peter Kedron & Jennifer Scully, 2011. "A Study of R&D, Collaboration, and Location Preferences of Health and Agricultural Biotech Firms," Environment and Planning C, , vol. 29(3), pages 473-486, June.
    5. Fiedler, Marina & Welpe, Isabell M., 2010. "Antecedents of cooperative commercialisation strategies of nanotechnology firms," Research Policy, Elsevier, vol. 39(3), pages 400-410, April.
    6. Mohammed Benmahidi, 2004. "Les rapprochements stratégiques inter-firmes le cas de l’industrie pharmaceutique (Strategic partnerships between firms the case of the pharmaceutical industry)," Working Papers 90, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
    7. Corine Genet & Khalid Errabi & Caroline Gauthier, 2012. "Which Model of Technology Transfer for Nanotechnology? A Comparison with Biotech and Microelectronics," Post-Print hal-00749152, HAL.
    8. Contractor, F. J. & Lorange, P., 2002. "The growth of alliances in the knowledge-based economy," International Business Review, Elsevier, vol. 11(4), pages 485-502, August.
    9. Murmann, Johann Peter & Ozdemir, Salih Zeki & Sardana, Deepak, 2015. "The role of home country demand in the internationalization of new ventures," Research Policy, Elsevier, vol. 44(6), pages 1207-1225.
    10. Thakur, Ramendra & Hale, Dena, 2013. "Service innovation: A comparative study of U.S. and Indian service firms," Journal of Business Research, Elsevier, vol. 66(8), pages 1108-1123.
    11. Catherine Beaudry, 2011. "Collaboration and contracting out versus funding and support – Impact on the propensity to patent of Canadian biotechnology firms 1999-2005," CIRANO Working Papers 2011s-62, CIRANO.
    12. Shakeri, Roya & Radfar, Reza, 2017. "Antecedents of strategic alliances performance in biopharmaceutical industry: A comprehensive model," Technological Forecasting and Social Change, Elsevier, vol. 122(C), pages 289-302.
    13. Rothaermel, Frank T., 2001. "Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry," Research Policy, Elsevier, vol. 30(8), pages 1235-1251, October.
    14. Sharmistha Bagchi-Sen & Helen Lawton Smith & Linda Hall, 2004. "The US Biotechnology Industry: Industry Dynamics and Policy," Environment and Planning C, , vol. 22(2), pages 199-216, April.
    15. Kasch, Silja & Dowling, Michael, 2008. "Commercialization strategies of young biotechnology firms: An empirical analysis of the U.S. industry," Research Policy, Elsevier, vol. 37(10), pages 1765-1777, December.
    16. Luis Rubalcaba Bermejo & Stefka Slavova & Maria Deborah Kim & Fernando Merino De Lucas & Ernesto Franco-Temple & Jessica Michelle Victor, 2017. "Innovation for Productivity Growth in Ecuador," World Bank Publications - Reports 28295, The World Bank Group.
    17. Arnaud Le Van, 2020. "Les barrières pour le développement de produits verts et la rentabilité des PME vietnamiennes," Working Papers hal-02482057, HAL.
    18. Hopkins, Michael M. & Nightingale, Paul, 2006. "Strategic risk management using complementary assets: Organizational capabilities and the commercialization of human genetic testing in the UK," Research Policy, Elsevier, vol. 35(3), pages 355-374, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
    2. Dushnitsky, Gary & Lenox, Michael J., 2005. "When do incumbents learn from entrepreneurial ventures?: Corporate venture capital and investing firm innovation rates," Research Policy, Elsevier, vol. 34(5), pages 615-639, June.
    3. Franco Malerba & Luigi Orsenigo, 2000. "Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening," KITeS Working Papers 124, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Jan 2001.
    4. Colombo, Massimo G. & Grilli, Luca & Piva, Evila, 2006. "In search of complementary assets: The determinants of alliance formation of high-tech start-ups," Research Policy, Elsevier, vol. 35(8), pages 1166-1199, October.
    5. Rothaermel, Frank T., 2001. "Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry," Research Policy, Elsevier, vol. 30(8), pages 1235-1251, October.
    6. Jaideep Anand & Raffaele Oriani & Roberto S. Vassolo, 2010. "Alliance Activity as a Dynamic Capability in the Face of a Discontinuous Technological Change," Organization Science, INFORMS, vol. 21(6), pages 1213-1232, December.
    7. Richard Harris & John Moffat, 2011. "R&D, Innovation and Exporting," SERC Discussion Papers 0073, Centre for Economic Performance, LSE.
    8. Markus Solf, 2004. "Unternehmenskooperationen als Folge von Informations- und Kommunikations-technologieveränderungen: Eine theoretische Analyse," Schmalenbach Journal of Business Research, Springer, vol. 56(2), pages 146-167, March.
    9. Figueroa, Nicolás & Serrano, Carlos J., 2019. "Patent trading flows of small and large firms," Research Policy, Elsevier, vol. 48(7), pages 1601-1616.
    10. Veugelers, Reinhilde, 1997. "Internal R & D expenditures and external technology sourcing," Research Policy, Elsevier, vol. 26(3), pages 303-315, October.
    11. Gambardella, Alfonso & Giuri, Paola & Luzzi, Alessandra, 2007. "The market for patents in Europe," Research Policy, Elsevier, vol. 36(8), pages 1163-1183, October.
    12. Czarnitzki, Dirk & Hottenrott, Hanna, 2012. "Collaborative R&D as a strategy to attenuate financing constraints," ZEW Discussion Papers 12-049, ZEW - Leibniz Centre for European Economic Research.
    13. Woojin Yoon & Suyeon Kwon, 2023. "The Impact of Technological and Non-technological Innovative Activities on Technological Competitiveness," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 14(1), pages 1-19, March.
    14. Feng Zhang & Guohua Jiang, 2019. "Combination of Complementary Technological Knowledge to Generate “Hard to Imitate” Technologies," Journal of Information & Knowledge Management (JIKM), World Scientific Publishing Co. Pte. Ltd., vol. 18(02), pages 1-24, June.
    15. Paola Giuri & John Hagedoorn & Myriam Mariani, 2002. "Technological Diversification and Strategic Alliances," LEM Papers Series 2002/04, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
    16. Zhang, Jing & Baden-Fuller, Charles & Mangematin, Vincent, 2007. "Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry," Research Policy, Elsevier, vol. 36(4), pages 515-528, May.
    17. Gérard Ballot & Fathi Fakhfakh & Fabrice Galia & Ammon Salter, 2011. "The Fateful Triangle Complementarities between product, process and organizational innovation in the UK and France," Working Papers halshs-00812141, HAL.
    18. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
    19. Materia, Valentina & Pascucci, Stefano & Dries, Liesbeth, 2015. "Are in-house and outsourcing innovation strategies interlinked? Evidence from the European agri-food sector," 2015 Conference, August 9-14, 2015, Milan, Italy 212449, International Association of Agricultural Economists.
    20. Kollmer, Holger & Dowling, Michael, 2004. "Licensing as a commercialisation strategy for new technology-based firms," Research Policy, Elsevier, vol. 33(8), pages 1141-1151, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:24:y:1995:i:4:p:609-630. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.